Real-time interpretable data
for clinical trials.

From small connected devices to large Phase 4

Cloud-native detection and response for clinical data.

Get interpretable data into decision making of your customers from patient to CEO in a fraction of the time it takes today.

 

 


Therapeutic areas

Patient compliance automation for clinical trials

Women’s reproductive health

Reduction of patient burden in a study and extremely fast detection of protocol deviations and adverse events are key to success in gynecology studies. The combination of low-touch data collection, passive sensors and real-time detection and response enables the executive team to perform studies on-time and under budget.

Patient compliance automation for clinical trials

Pain

The difference between a futile study and a successful one is the ability to get near-real-time alerts regarding even small deviations from the protocol, communicate with the patient and resolve issues in real-time. For patients at home, fast detection and response enable the clinical operations team to achieve extremely high protocol compliance.

Patient compliance automation for clinical trials - shaking hands

Chronic diseases

Chronic disease studies are conducted in real-world conditions with the patient at home. With AI-based detection and response and adaptive reinforcement of patient adherence, the CxO team can confidently complete studies and submission milestones on time and under budget.

Overview

Real time data

Mobile EDC, Mobile ePRO, Flask API for devices and apps

Automated detection

Immediate picture of protocol compliance across sites, patients, cohorts

Automated response

Notify the sponsor, site team or patient now. No need to wait for next site monitoring visit.

Your control

Your own measures, your own real-time alerts your own visual analytics of compliance trends.

Unlimited usage subscription

Unlimited users, data, sites, analytics.

We help life science executive teams outcompete

Verified data for decisions

Click here to learn more